Conservative management of < 3cm anterior mediastinal lesions in lung cancer screening is safe - Summary - MDSpire

Conservative management of < 3cm anterior mediastinal lesions in lung cancer screening is safe

  • By

  • Amyn Bhamani

  • Chuen R. Khaw

  • Ruth Prendecki

  • Priyam Verghese

  • Andrew Creamer

  • Jennifer L. Dickson

  • Carolyn Horst

  • Helen Hall

  • Sophie Tisi

  • Monica Mullin

  • Tanya Patrick

  • John McCabe

  • Anne-Marie Hacker

  • Laura Farrelly

  • Esther Arthur-Darkwa

  • Neal Navani

  • Anand Devaraj

  • Allan Hackshaw

  • Arjun Nair

  • Sam M. Janes

  • July 4, 2026

  • 0 min

Share

Objective:

To assess outcomes for participants with anterior mediastinal lesions < 3 cm at baseline and determine if a conservative approach to managing such lesions is safe.

Approach:
  • Study Design: Retrospective analysis of anterior mediastinal lesions identified during the SUMMIT LCS Study, focusing on lesions < 3 cm.
  • Participant Criteria: Participants were aged 55–77, current or former smokers, meeting specific lung cancer risk criteria.
  • Imaging Protocol: Participants underwent non-contrast LDCT imaging, with follow-up scans at 12 and 24 months.
  • Management Protocol: Lesions ≥ 3 cm or with concerning features were referred for further assessment; lesions < 3 cm were managed conservatively.
Key Findings:
  • The prevalence of anterior mediastinal lesions in the cohort was reported as part of the analysis.
  • Outcomes for individuals referred to secondary care for further investigation were documented.
Interpretation:

The study aims to inform management protocols for incidental anterior mediastinal lesions detected during lung cancer screening.

Limitations:
  • The study is retrospective and may not capture all relevant outcomes.
  • The generalizability of findings may be limited to the specific population studied.
Conclusion:

Further research is needed to establish standardized protocols for managing anterior mediastinal lesions < 3 cm.

Original Source(s)

Conservative management of < 3cm anterior mediastinal lesions in lung cancer screening is safe

  • by Amyn Bhamani, Chuen R. Khaw, Ruth Prendecki, Priyam Verghese, Andrew Creamer, Jennifer L. Dickson, Carolyn Horst, Helen Hall, Sophie Tisi, Monica Mullin, Tanya Patrick, John McCabe, Anne-Marie Hacker, Laura Farrelly, Esther Arthur-Darkwa, Neal Navani, Anand Devaraj, Allan Hackshaw, Arjun Nair, Sam M. Janes

  • July 4, 2026

Related Content

EGP-Net: a lung nodule segmentation network integrating edge guidance and pyramidal multi-scale contextual attention mechanisms

European consensus on pre-operative imaging in breast cancer developed jointly by EUSOBI, ESSO, ESP and ESTRO

Dynamic uncertainty-level assessment framework for real-time needle tracking in CT-guided surgical environments